Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MaRaBoo rabies booster antibody response study in Dutch marines
NL-OMON45312Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2016
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of Rabies vaccine in rabies, sponsored by Amsterdam University Medical Center. Primary endpoints: Participants with rabies antibody titer at or above 0.5 IU/mL on day 7 and Participants with rabies antibody titer at or above 0.5 IU/mL on day 14. Started Nov 2016; status: active, not recruiting.
02
Drugs
Rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on NL-OMON45312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45312.